In his keynote speech at Ending Age-Related Diseases 2020, Dr. Aubrey de Grey of SENS Research Foundation discusses the current state of the rejuvenation biotechnology industry in the context of the current pandemic. He mentions the failure of Unity Biotechnology’s Phase 2 clinical trial for osteoarthritis, COVID-19 and the elderly immune system, the current popularization of rejuvenation biotechnology, XPRIZE, and the steps that are currently being taken towards a world without age-related diseases.
HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
Alpha-lipoic acid (also known as ALA) is a common supplement and we take a look at it in the context of aging. What is Alpha-lipoic acid? Alpha-lipoic acid is an organosulfur (an organic compound that […]
Journal Club returns on July 27th at noon Eastern / 17:00 UK live on our Facebook page. A new way to look at Alzheimer’s The topic for this month will be a new study that challenges the amyloid hypothesis […]
The cryptocurrency world is colliding with aging research and life extension and could change how research gets funded. The cryptocurrency community is getting behind healthy life extension The landscape of research funding […]
Researchers have used a big data approach to disentangle cellular and physiological changes that are specific to COVID-19 from those caused by aging […]
On this episode of X10, we talk about the how the gut microbiome is connected with aging and the role of gut bacteria in the immune response. Script You’ve probably heard about the gut microbiome, […]
A report in the Journal of Cell Science has outlined different stages of cellular senescence alongside a mechanism that reverses it, along with a potential new treatment for […]
This week on Lifespan News, Brent Nally discusses Pulse Chain, a blockchain-based cryptocurrency that is being used to donate to SENS Research Foundation. Further Reading […]
Write a comment: